Skip to main content

Year: 2025

Form 8.5 (EPT/RI)-TT Electronics plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree TT Electronics plc(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Financial Adviser to DBAY(d)        Date dealing undertaken: 09th December 2025(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or possible cash offer, state...

Continue reading

Form 8.3 – [IDOX PLC – 09 12 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Form 8.3 – [IQE PLC – 09 12 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Advantest Introduces Next-Generation M5241 Memory Handler to Support High-Performance AI Memory Devices

New platform delivers high-precision temperature control, maximized uptime, and enhanced maintainability to facilitate advanced memory testM5241 Memory HandlerNext-generation M5241 Memory Handler to support high-performance AI memory devicesTOKYO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced the M5241 Memory Handler, its next-generation handler developed to meet the performance, automation and cost-efficiency demands of emerging high-performance memory devices—particularly those used in artificial intelligence (AI) applications. First shipments of the new handler are scheduled for Q2 of calendar year 2026. Engineered as the next evolution of Advantest’s memory test cell strategy, the M5241 utilizes vertical docking to integrate seamlessly...

Continue reading

LIFT Identifies Thousands of Spodumene Grains in an Indicator Mineral Study at the Nottaway Lithium Project, Quebec

VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) — Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to provide an update on the exploration results from the Nottaway Lithium Project (the “Project”), located in the Eeyou Istchee Region of Québec. During the summer of 2025, LIFT collected 49 till samples for indicator mineral analysis in areas with very limited outcrop. The samples were processed by Overburden Drilling Management (ODM), where density concentrates were produced to identify spodumene grains that could signal the presence of nearby spodumene-bearing pegmatites hidden beneath till cover. This work outlined a 1 x 3 km area of elevated spodumene grain counts within the Project area, highlighting the potential presence of a concealed pegmatite system under cover...

Continue reading

Kitron receives EUR 55 million defence order

(2025-12-10) Kitron has received an order with a value of EUR 55 million from a customer in the Defence/Aerospace market sector. “This order is yet another example of the strong demand we have reported in the defence sector, and it confirms our agility and ability to rapidly scale,” says Peter Nilsson, CEO of Kitron. Deliveries are set to take place in 2026. For further information, please contact:Peter Nilsson, President and CEO, tel. +47 948 40 850Hans Petter Thomassen, VP Nordics and North America tel. +47 91392360Email: investorrelations@kitron.com Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The group has operations located in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic,...

Continue reading

Karolinska Development’s portfolio company AnaCardio presents positive top-line data from the phase 2a study of its drug candidate AC01

STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has reported strong, positive results from the phase 2a clinical trial GOAL-HF1, evaluating the drug candidate AC01 in patients with heart failure and reduced ejection fraction (HFrEF). The study met its primary endpoint, demonstrating a favorable safety and tolerability profile, and showed encouraging, consistent efficacy signals paving the way for a rapid advancement to phase 2b. AnaCardio AB is a privately held Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure. The company has recently concluded a clinical phase 2a study with its lead asset, AC01, , demonstrating a favorable safety and tolerability profile, which was the study’s primary endpoint. While...

Continue reading

Viridien announces new seismic reimaging program over block 22 offshore Angola to support upcoming licensing round

Paris, France – December 10, 2025 Viridien has announced a new multi-client seismic reimaging program over Angola’s highly prospective offshore block 22 to support the country’s upcoming licensing round. The 4,300 sq km high-end data set will bring valuable insight into underexplored structures along the Atlantic Hinge zone, following the same trend as the proven Cameia and Golfinho fields. Fast-track results are scheduled for delivery in Q1 2026 and final products in Q3/Q4 2026. Viridien will reimage the block 22 data set with its latest proven proprietary technologies, including time-lag FWI, Q-FWI, Q-Kirchhoff and advanced deghosting and demultiple. This data will complement its 2,900 sq km of data over nearby block 20/11, giving operators access to a combined regional coverage of over 7,200 sq km of ultramodern broadband PSDM data...

Continue reading

Sampo plc’s share buybacks 9 December 2025

Sampo plc, stock exchange release, 10 December 2025 at 8:30 am EET Sampo plc’s share buybacks 9 December 2025 On 9 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  9,990 10.04 AQEU    111,762 10.04 CEUX  36,071 10.04 TQEX  102,332 10.04 XHELTOTAL 260,155 10.04  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

Fnac Darty announces full buy-in of UK pension scheme

Ivry-sur-Seine, France, 10 December 2025, 7h45 FNAC DARTY ANNOUNCES FULL BUY-IN OF UK PENSION SCHEME Fnac Darty today announces that it has reached an agreement with the Trustee of the Comet Pension Scheme in the UK to fully insure the Scheme’s liabilities through a £330 million full buy-in with Canada Life UK. The transaction secures the long-term benefits of all Scheme members by transferring the financial risk associated with future pension payments to a highly rated insurer. This marks a major de-risking milestone for Fnac Darty, providing greater cost certainty and strengthening its long-term financial position. The Scheme was part of Darty’s legacy UK operations and became part of the group following the acquisition of Darty in 2016. Under the terms of the agreement with the Trustee, this operation has no material impact on the Group’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.